31 December 2014
Last updated at 15:37
Pauline Cafferkey is an associate public health nurse at Blantyre Health Centre, South Lanarkshire
Ebola patient Pauline Cafferkey is receiving an experimental anti-viral drug and blood from survivors of the disease, doctors in London have said.
Specialists at the Royal Free Hospital in Hampstead, where the nurse is being treated, did not name the drug.
Dr Michael Jacobs said Ms Cafferkey was in isolation and was sitting up in bed, talking and reading.
As the disease has no cure and is unpredictable, Dr Jacobs said they would know more in a week’s time.
He said Ms Cafferkey had agreed to all the treatments and her family had been to see her.
“She’s a nurse, a fellow professional, so we have been able to discuss things in great detail,” he said.
“She’s as well as we can hope for at this stage of the illness. She’s had the treatment, it’s gone very smoothly, no side-effects at all.”
The drug and the blood plasma are part of a tranche of experimental treatments, he said.
“We simply don’t know what the best treatment strategies are,” he added.
He said there was “a European pool” of recovered patients’ blood plasma and they had identified “the best plasma for her”.
It is hoped the antibodies in the plasma will help her immune system fight the disease.
Ms Cafferkey, a public health nurse at Blantyre Health Centre in South Lanarkshire, is receiving treatment via a quarantine tent after returning to Glasgow from Sierra Leone on Sunday.
She was working in the West African country as part of a Save the Children team.
Ms Cafferkey had travelled from Freetown in Sierra Leone via Casablanca